Asteroid 2024 YR4, though not an Earth threat, now poses a collision risk to the Moon. Scientists estimate a 4.3% chance of ...

BioOrbit CEO Dr Katie King said that pre-clinical studies of the crystals produced in space could start as early as 2026.

Axiom Space’s fourth commercial mission to the International Space Station has been pushed back once more amid growing concerns of an air leak in the Russian segment of the orbiting lab.